Mebeverine Hydrochloride Ibs Aspire Pharma (Malta) (Mebeverine Hydrochloride)

Mebeverine acts as a direct smooth‑muscle relaxant in the gastrointestinal tract. By inhibiting calcium influx into muscle cells, it lowers intracellular calcium levels, which reduces muscle contractility and eases spasms without significantly affecting normal motility.

The appropriate dose of mebeverine is determined by the prescribing clinician based on the patient’s condition, severity of symptoms, and overall health status. Patients should follow the dosage instructions provided by their healthcare professional.

Safety data for mebeverine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting therapy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Mebeverine differs from many anticholinergic antispasmodics because it relaxes smooth muscle without significant anticholinergic side effects such as dry mouth or blurred vision. This profile may make it preferable for patients who are sensitive to anticholinergic burden.

Mebeverine Hydrochloride Ibs Aspire Pharma should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, and store it out of direct sunlight to maintain stability.

Mebeverine is administered orally, typically as a tablet or capsule, and should be taken with or without food as directed by the prescriber. Patients should swallow the dosage form whole with water and not crush or chew it unless instructed otherwise.

Serious but rare risks include allergic reactions such as rash, swelling, or difficulty breathing, as well as cardiac palpitations and severe abdominal pain. Any signs of these reactions require immediate medical attention.

Individuals with known hypersensitivity to mebeverine or any of its excipients should not use the product. Patients with severe liver impairment, uncontrolled cardiac conditions, or those taking medications that may cause major interactions should consult their physician before starting therapy.